These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 26160658)

  • 21. Is there another possible approach to inhibit wear particles-induced inflammatory osteolysis?
    Liu YP; Yu GR; Li K; Yuan F
    Med Hypotheses; 2011 Feb; 76(2):280-2. PubMed ID: 21067868
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Improved osseointegration and periprosthetic bone volume around cementless metal implants under bisphosphonate treatment].
    Eberhardt C; Raussen W; Thiemann S; Schwarz M; Bauss F; Kurth AA
    Z Orthop Ihre Grenzgeb; 2005; 143(6):645-51. PubMed ID: 16380896
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of hydroxyapatite coating in resisting wear particle migration and osteolysis around acetabular components.
    Coathup MJ; Blackburn J; Goodship AE; Cunningham JL; Smith T; Blunn GW
    Biomaterials; 2005 Jul; 26(19):4161-9. PubMed ID: 15664643
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The decrease of particle-induced osteolysis after a single dose of bisphosphonate.
    von Knoch M; Wedemeyer C; Pingsmann A; von Knoch F; Hilken G; Sprecher C; Henschke F; Barden B; Löer F
    Biomaterials; 2005 May; 26(14):1803-8. PubMed ID: 15576154
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantitative small-animal surrogate to evaluate drug efficacy in preventing wear debris-induced osteolysis.
    Schwarz EM; Benz EB; Lu AP; Goater JJ; Mollano AV; Rosier RN; Puzas JE; Okeefe RJ
    J Orthop Res; 2000 Nov; 18(6):849-55. PubMed ID: 11192243
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Wear particles of total joint replacements and their role in periprosthetic osteolysis.
    Jasty M; Smith E
    Curr Opin Rheumatol; 1992 Apr; 4(2):204-9. PubMed ID: 1581149
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypericin suppresses osteoclast formation and wear particle-induced osteolysis via modulating ERK signalling pathway.
    Ouyang Z; Zhai Z; Li H; Liu X; Qu X; Li X; Fan Q; Tang T; Qin A; Dai K
    Biochem Pharmacol; 2014 Aug; 90(3):276-87. PubMed ID: 24950468
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Experimental pilot study on surface activation of implants with liposomal vectors].
    Thorwarth M; Schlegel KA; Wiltfang J; Rupprecht S; Park JH
    Mund Kiefer Gesichtschir; 2004 Jul; 8(4):250-5. PubMed ID: 15293121
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Radiographic changes around humeral components in shoulder arthroplasty.
    Raiss P; Edwards TB; Deutsch A; Shah A; Bruckner T; Loew M; Boileau P; Walch G
    J Bone Joint Surg Am; 2014 Apr; 96(7):e54. PubMed ID: 24695931
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Conus hip prosthesis.
    Wagner H; Wagner M
    Acta Chir Orthop Traumatol Cech; 2001; 68(4):213-21. PubMed ID: 11706545
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of systemic bisphosphonate delivery on osseointegration of implants under osteoporotic conditions: lessons from animal studies.
    Vohra F; Al-Rifaiy MQ; Almas K; Javed F
    Arch Oral Biol; 2014 Sep; 59(9):912-20. PubMed ID: 24908376
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Results of pamidron acid application in prevention of instability of bones implants].
    Dedkov AG
    Lik Sprava; 2009; (7-8):66-8. PubMed ID: 20455451
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of pretreating morselized allograft bone with rhBMP-2 and/or pamidronate on the fixation of porous Ti and HA-coated implants.
    Baas J; Elmengaard B; Jensen TB; Jakobsen T; Andersen NT; Soballe K
    Biomaterials; 2008 Jul; 29(19):2915-22. PubMed ID: 18407348
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The effect of ultra high molecular weight polyethylene particle on the tissues of joint prosthesis].
    Lu W; Liao W; Yu N; Luo X; Bai B; Lin Z; Gu Y; Liu M; Chen G; Yang T
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2005 Jan; 19(1):54-7. PubMed ID: 15704845
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alveolar ridge augmentation using implants coated with recombinant human bone morphogenetic protein-2: histologic observations.
    Wikesjö UM; Qahash M; Polimeni G; Susin C; Shanaman RH; Rohrer MD; Wozney JM; Hall J
    J Clin Periodontol; 2008 Nov; 35(11):1001-10. PubMed ID: 18976397
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Strontium in the bone-implant interface.
    Vestermark MT
    Dan Med Bull; 2011 May; 58(5):B4286. PubMed ID: 21535993
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The significance of wear and material fatigue in loosening of hip prostheses].
    Willert HG; Buchhorn GH; Hess T
    Orthopade; 1989 Sep; 18(5):350-69. PubMed ID: 2682455
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Denosumab for treating periprosthetic osteolysis; study protocol for a randomized, double-blind, placebo-controlled trial.
    Sköldenberg O; Rysinska A; Eisler T; Salemyr M; Bodén H; Muren O
    BMC Musculoskelet Disord; 2016 Apr; 17():174. PubMed ID: 27108405
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Management of extensive tibial osteolysis with the Agility™ total ankle replacement systems using geometric metal-reinforced polymethylmethacrylate cement augmentation.
    Prissel MA; Roukis TS
    J Foot Ankle Surg; 2014; 53(1):101-7. PubMed ID: 24370485
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metal ions as inflammatory initiators of osteolysis.
    Magone K; Luckenbill D; Goswami T
    Arch Orthop Trauma Surg; 2015 May; 135(5):683-95. PubMed ID: 25795427
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.